Manufacturing facility
Production Facility
Production Facility
Why Partnering with Radiant Pharmaceuticals Ltd.?

Radiant's Chairman, with twenty years of experience in multinational pharmaceutical companies, leads a young team of highly motivated, innovative, and skilled professionals. Most of our executives at Radiant have worked in both national and multinational corporate environments. That's what gives Radiant the confidence to look beyond the horizon.

When partnering with Radiant, you will encounter a multifaceted crowd of employees adhering to Good Manufacturing Practices (GMP). To the mutual benefit of all parties, we implement such practices through cost effective systems compliant with regulatory requirements across all functions.

Radiant is committed to ethical compliance, quality assurance and a caring approach towards customers as well as employees.

Currently Radiant manufactures in its own manufacturing facilities several products of F. Hoffmann-La Roche Ltd., Switzerland under licensee agreement. These partnerships have provided Radiant much valuable expertise and know-how in manufacturing world-class products.

If you are looking to outsource and cut your production costs we can be an ideal partner to meet your contract manufacturing needs. Our company has a sound professional track record and its management maintains international standards, in keeping with the work culture of a multinational company.

Radiant offers significant cost advantages as a manufacturer. Average wages in Bangladesh are perhaps the lowest in the world, and at least two to three times less than in China or India. Prospective partners can benefit from competitive advantages of skilled manpower at low cost, low energy cost, government policy support and an investor friendly environment.

Radiant welcomes information about new business opportunities. Each opportunity is carefully evaluated and reviewed by our dedicated team. If you are working on something fresh with prospective value for patients, we encourage you to contact us.